A Single-Centre, Open-Label, One-Sequence, Crossover Study to Investigate the Effects of Multiple Doses of Carbamazepine on the Pharmacokinetics of a Single Dose RO4917523 in Healthy Subjects

Trial Profile

A Single-Centre, Open-Label, One-Sequence, Crossover Study to Investigate the Effects of Multiple Doses of Carbamazepine on the Pharmacokinetics of a Single Dose RO4917523 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Basimglurant (Primary) ; Carbamazepine
  • Indications Bipolar disorders; Epilepsy; Fragile X syndrome; Major depressive disorder
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 25 Mar 2013 Actual end date (Oct 2012) added as reported by ClinicalTrials.gov.
    • 19 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top